Literature DB >> 20981772

The behavioral phenotype of the Angelman syndrome.

Charles A Williams1.   

Abstract

The Angelman syndrome is clinically delineated by the combination of seizures, absent speech, hypermotoric and ataxic movements and certain remarkable behaviors. Those with the syndrome have a predisposition toward apparent happiness and paroxysms of laughter, and this finding helps distinguish Angelman syndrome from other ones involving severe developmental handicap. In this review the core neurological features of the syndrome are discussed with a focus on those behaviors that make Angelman syndrome a prototypical genetic disorder expressing a behavioral phenotype.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20981772     DOI: 10.1002/ajmg.c.30278

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  32 in total

1.  Sleep in children and adolescents with Angelman syndrome: association with parent sleep and stress.

Authors:  S E Goldman; T J Bichell; K Surdyka; B A Malow
Journal:  J Intellect Disabil Res       Date:  2011-11-02

2.  Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.

Authors:  Gustavo Martínez-Noël; Jeffrey T Galligan; Mathew E Sowa; Verena Arndt; Thomas M Overton; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

3.  Neurodevelopmental disease: A molecular tightrope.

Authors:  Ype Elgersma
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

4.  Social-emotional processing in nonverbal individuals with Angelman syndrome: evidence from brain responses to known and novel names.

Authors:  A P Key; D Jones
Journal:  J Intellect Disabil Res       Date:  2018-11-23

5.  Disrupted Functional and Structural Connectivity in Angelman Syndrome.

Authors:  H M Yoon; Y Jo; W H Shim; J S Lee; T S Ko; J H Koo; M S Yum
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

Review 6.  Vagal nerve stimulation for medically refractory epilepsy in Angelman syndrome: a series of three cases.

Authors:  Krystal L Tomei; Christine Y Mau; Michael Ghali; Jayoung Pak; Ira M Goldstein
Journal:  Childs Nerv Syst       Date:  2018-01-19       Impact factor: 1.475

7.  Molecular and Clinical Aspects of Angelman Syndrome.

Authors:  A Dagli; K Buiting; C A Williams
Journal:  Mol Syndromol       Date:  2011-07-28

8.  The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.

Authors:  Kathryn H Condon; Jianghai Ho; Camenzind G Robinson; Cyril Hanus; Michael D Ehlers
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

Review 9.  Angelman syndrome - insights into a rare neurogenetic disorder.

Authors:  Karin Buiting; Charles Williams; Bernhard Horsthemke
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

10.  Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.

Authors:  Andie Dodge; Melinda M Peters; Hayden E Greene; Clifton Dietrick; Robert Botelho; Diana Chung; Jonathan Willman; Austin W Nenninger; Stephanie Ciarlone; Siddharth G Kamath; Pavel Houdek; Alena Sumová; Anne E Anderson; Scott V Dindot; Elizabeth L Berg; Henriette O'Geen; David J Segal; Jill L Silverman; Edwin J Weeber; Kevin R Nash
Journal:  Autism Res       Date:  2020-01-21       Impact factor: 5.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.